Naloxone Clinical Trial
Official title:
Addressing the Opioid Epidemic Through Community Pharmacy Engagement: Randomized Controlled Trial (Aim 2)
This is a pilot Randomized Controlled Trial (RCT) in which 120 pharmacists will be randomized to an experimental or control group and data on naloxone dispensing and secondary outcomes will be collected over the course of the RCT.
This is a prospective pilot RCT that will evaluate the impact of naloxone communication training (Nalox-Comm) on 120 pharmacists' naloxone dispensing behaviors (primary outcome). Data will be collected at baseline, immediately after training is completed, and at 3-month follow up. Data sources include pharmacy records (for naloxone dispensing), simulated patient observations (to rate quality of communication), and survey data (for self-reports of knowledge and self-efficacy). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03280966 -
Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder
|
Phase 2 | |
| Completed |
NCT00723697 -
Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)
|
||
| Completed |
NCT01935206 -
Effect of High Dose Naloxone on Secondary Hyperalgesia
|
Phase 1 | |
| Completed |
NCT04303000 -
Increasing Naloxone Access for Persons Who Use Opioids
|
Phase 4 | |
| Not yet recruiting |
NCT06251609 -
Naloxone for Opioid Associated Out of Hospital Cardiac Arrest
|
Phase 2 | |
| Enrolling by invitation |
NCT03430180 -
Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder
|
Phase 2 | |
| Completed |
NCT03223896 -
Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray
|
Phase 2 | |
| Completed |
NCT04025671 -
A Usability Assessment of Naloxone Administration by Untrained Community Members
|
N/A |